Frederick Feit
YOU?
Author Swipe
View article: Revisiting the Efficacy and Safety of Bivalirudin in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From a Mixed Treatment Comparison Meta‐Analysis of Randomized Trials
Revisiting the Efficacy and Safety of Bivalirudin in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From a Mixed Treatment Comparison Meta‐Analysis of Randomized Trials Open
Background Randomized trials of bivalirudin in patients with ST elevation myocardial infarction (STEMI) have yielded heterogeneous results. Aims Our aim was to evaluate the efficacy and safety of four antithrombin regimens—unfractionated h…
View article: Novel approach to stenting the left anterior descending coronary artery through a retrograde approach via the left internal mammary artery graft in a patient with occlusion of the coronary ostium from a prior aortic valve replacement
Novel approach to stenting the left anterior descending coronary artery through a retrograde approach via the left internal mammary artery graft in a patient with occlusion of the coronary ostium from a prior aortic valve replacement Open
Total occlusion of both coronary ostia is a rare and potentially life‐threatening complication following surgical aortic valve replacement. This report presents a case of a patient with known total occlusion of both coronary artery ostia f…
View article: Toward Personalized DAPT: Is There an Inter-Manufacturer Difference in Generic Clopidogrel Response?
Toward Personalized DAPT: Is There an Inter-Manufacturer Difference in Generic Clopidogrel Response? Open
In a large public hospital, we observed that pharmacodynamic response to clopidogrel varied by drug manufacturer. Further investigation and/or regulation is needed to minimize inter-manufacturer variability.
View article: Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic
Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic Open
There was a dramatic decrease in the number of patients with MI undergoing coronary angiography during the first wave of the COVID-19 pandemic. Of those who presented, patients tended to seek care later after symptom onset and had excess m…
View article: Impact of the <scp>COVID</scp>‐19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter
Impact of the <span>COVID</span>‐19 pandemic on interventional cardiology fellowship training in the New York metropolitan area: A perspective from the United States epicenter Open
Background The healthcare burden posed by the coronavirus disease 2019 (COVID‐19) pandemic in the New York Metropolitan area has necessitated the postponement of elective procedures resulting in a marked reduction in cardiac catheterizatio…
View article: Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention
Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention Open
Background: Vascular injury and inflammation during percutaneous coronary intervention (PCI) are associated with increased risk of post-PCI adverse outcomes. Colchicine decreases neutrophil recruitment to sites of vascular injury. The anti…
View article: The assessment of thrombotic markers utilizing ionic versus non‐ionic contrast during coronary angiography and intervention trial
The assessment of thrombotic markers utilizing ionic versus non‐ionic contrast during coronary angiography and intervention trial Open
Objective To determine how two different types of iodinated contrast media (CM), low‐osmolar ionic dimer ioxaglate (Hexabrix) and iso‐osmolar non‐ionic dimer iodixanol (Visipaque), affect multiple indices of hemostasis. Background In vitro…